Liquid chromatographic method for the simultaneous determination of caffeine and fourteen caffeine metabolites in urine

被引:41
作者
Bendriss, EK
Markoglou, N
Wainer, IW [1 ]
机构
[1] McGill Univ, Dept Oncol, Pharmacokinet Div, Montreal, PQ, Canada
[2] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA
来源
JOURNAL OF CHROMATOGRAPHY B | 2000年 / 746卷 / 02期
关键词
caffeine;
D O I
10.1016/S0378-4347(00)00325-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An HPLC method has been developed for the separation and the determination of caffeine and its metabolites in urine samples using a one extraction-analysis run and UV detection. The compounds were extracted by liquid-liquid extraction using chloroform-isopropylalcohol (85:15, v/v). Chromatographic separation was accomplished on an ODS analytical column with a mobile phase containing 0.05% acetic acid/methylalcohol (92.5:7.5, v/v). Compounds were monitored at 280 nm. The method was validated for the determination of AFMU, 1X, 1U, 17X and 17U caffeine metabolites required to assess the metabolic activity of the enzymes subject to in vivo caffeine testing. The validated assay was applied to urine samples from ten healthy volunteers. The method was proved to be suitable to assess simultaneously the enzymatic activity of cytochrome P450 CYP1A2 and CYP2A6, as well as N-acetyltransferase and xanthine oxidase. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 18 条
[1]  
Arnaud MJ, 1993, CAFFEINE COFFEE HLTH, P43
[2]  
BECHTEL P, 1983, ANN BIOL CLIN, V4, P361
[3]   Histamine, xanthine oxidase generated oxygen-derived free radicals and Helicobacter pylori in gastroduodenal inflammation and ulceration [J].
Ben-Hamida, A ;
Man, WK ;
McNeil, N ;
Spencer, J .
INFLAMMATION RESEARCH, 1998, 47 (04) :193-199
[4]   Acetylation polymorphism expression in patients before and after liver transplantation: influence of host/graft genotypes [J].
Bendriss, EK ;
Bechtel, YC ;
Paintaud, G ;
Brientini, MP ;
Mantion, G ;
Miguet, JP ;
Bennani, A ;
Bechtel, PR .
PHARMACOGENETICS, 1998, 8 (03) :201-209
[5]   A URINARY METABOLITE RATIO THAT REFLECTS SYSTEMIC CAFFEINE CLEARANCE [J].
CAMPBELL, ME ;
SPIELBERG, SP ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) :157-165
[6]   ACETYLATION PHENOTYPE AND CUTANEOUS HYPERSENSITIVITY TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HIV-INFECTED PATIENTS [J].
CARR, A ;
GROSS, AS ;
HOSKINS, JM ;
PENNY, R ;
COOPER, DA .
AIDS, 1994, 8 (03) :333-337
[7]  
EVANS DAP, 1989, PHARMACOL THERAPEUT, V42, P157
[8]   VARIABILITY IN CAFFEINE METABOLISM [J].
GRANT, DM ;
TANG, BK ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (05) :591-602
[9]   THE CYTOCHROME-P450-I GENE FAMILY OF MICROSOMAL HEMOPROTEINS AND THEIR ROLE IN THE METABOLIC-ACTIVATION OF CHEMICALS [J].
IOANNIDES, C ;
PARKE, DV .
DRUG METABOLISM REVIEWS, 1990, 22 (01) :1-85
[10]   THE USE OF CAFFEINE FOR ENZYME ASSAYS - A CRITICAL-APPRAISAL [J].
KALOW, W ;
TANG, BK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (05) :503-514